Indication
Reducing neutropenia in patients taking cancer treatments
Official EMA Resources
View on EMA (ema.europa.eu)AI Drug & Interaction Analysis
Loading your page…
Loading your page…
Marketing Authorisation Holder: Mylan S.A.S
INN: pegfilgrastim
AI Drug & Interaction Analysis
Free account required
Ask Osler about Fulphila: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.